Health Gene Technologies

Ningbo Health Gene Technologies Co., Ltd (HGT) is a wholly-owned subsidiary of Health BioMed Co., Ltd (HBM). HGT, found in 2011, has dedicated its business to gene fragment analysis application development. HGT has a 2000 m2 molecular diagnostic R&D laboratory and a 1000 m2 reagent production plant, in accordance with GMP. Equipped with state-of-the-art research and production facilities, HGT is committed to developing simple, rapid and effective nucleic acid testing solutions for molecular diagnostics, clinical research and forensic analysis. Inspired by our motto 'Health Technologies•Healthy Life', HGT cares not only about the products but also about environmental protection. HGT follows a comprehensive sustainability policy making the processes of research and manufacturing more environmentally friendly. In addition, HGT aims to help people achieve a better quality life by the development of its healthcare solutions. It dedicates to develop and manufacture Advanced Fragment Analysis (AFA) based in vitro diagnostic kits for many different applications, such as Pathogen Detection, Pharmacogenomics Analysis and Human DNA Identification.